Xometry, Inc.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
XMTR$119.31-1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows
(In thousands)
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Cash flows from operating activities: | |||
| Net loss | $(61,748) | $(50,403) | $(67,465) |
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Depreciation and amortization | 18,750 | 13,012 | 10,738 |
| Impairment of assets | 49 | 82 | 397 |
| Reduction in carrying amount of right-of-use asset | 4,638 | 4,458 | 14,355 |
| Lease termination | (14) | — | — |
| Stock-based compensation | 36,362 | 29,322 | 22,118 |
| Revaluation of contingent consideration | — | 137 | 571 |
| Income from unconsolidated joint venture | (90) | (42) | (46) |
| Donation of common stock | 3,272 | 1,686 | 1,029 |
| Loss on debt extinguishment | 16,430 | — | — |
| Loss on sale of property and equipment | — | 3 | 92 |
| Inventory write-off | — | — | 223 |
| Amortization of deferred costs on convertible notes | 2,098 | 1,859 | 1,860 |
| Deferred tax benefit | (84) | (46) | (154) |
| Changes in other assets and liabilities: | |||
| Accounts receivable, net | (21,809) | (5,749) | (20,594) |
| Inventory | 135 | (1,282) | (1,550) |
| Prepaid expenses | (2,256) | 599 | 1,669 |
| Other assets | (772) | 4,213 | (80) |
| Accounts payable and accrued cost of revenue | 9,160 | (8,706) | 12,593 |
| Other accrued expenses | 7,440 | 2,681 | 1,603 |
| Contract liabilities | 2,151 | 681 | (1,404) |
| Lease liabilities | (6,892) | (6,911) | (5,520) |
| Other liabilities | (24) | 527 | — |
| Income taxes payable | (710) | (1,505) | (312) |
| Net cash provided by (used in) operating activities | 6,086 | (15,384) | (29,877) |
| Cash flows from investing activities: | |||
| Purchases of marketable securities | (8,542) | (18,751) | (11,582) |
| Proceeds from sale of marketable securities | 22,000 | 16,500 | 50,000 |
| Purchases of property and equipment | (30,180) | (18,097) | (18,486) |
| Distributions in excess of earnings | 86 | 90 | — |
| Proceeds from sale of property and equipment | — | 79 | 223 |
| Cash paid for business combination, net of cash acquired | — | — | (3,349) |
| Net cash (used in) provided by investing activities | (16,636) | (20,179) | 16,806 |
| Cash flows from financing activities: | |||
| Proceeds from issuance of convertible notes | 250,000 | — | — |
| Costs incurred in connection with issuance of convertible notes | (8,650) | — | — |
| Payments for repurchase of convertible notes | (215,992) | — | — |
| Purchase of capped calls | (17,475) | — | — |
| Purchase of treasury stock | (8,080) | — | — |
| Proceeds from stock options exercised | 3,087 | 5,104 | 1,909 |
| Payment of contingent consideration | — | (465) | (842) |
| Net cash provided by financing activities | 2,890 | 4,639 | 1,067 |
| Effect of foreign currency translation on cash and cash equivalents | 424 | (268) | (234) |
| Net decrease in cash and cash equivalents | (7,236) | (31,192) | (12,238) |
| Cash and cash equivalents at beginning of the year | 22,232 | 53,424 | 65,662 |
| Cash and cash equivalents at end of the year | $14,996 | $22,232 | $53,424 |
| Supplemental cash flow information: | |||
| Cash paid for interest | $3,553 | $2,875 | $2,875 |
| Non-cash investing and financing activities: | |||
| Non-cash purchase of property and equipment | — | 1,059 | 5,353 |
| Non-cash consideration in connection with business combination | 625 | 625 | 1,593 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.